NOVARTIS AG Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 89,5 CHF | -0,56% |
|
+4,64% | +5,46% |
| 26/04 | NOVARTIS AG : Jefferies herhaalt koopadvies voor het aandeel | ZD |
| 24/04 | NOVARTIS AG : BMO Capital blijft neutraal | ZM |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 214.715 | 215.682 | 196.476 | 194.400 | 207.226 | 199.642 | - | - |
| Bedrijfswaarde 1 | 230.615 | 240.182 | 204.667 | 203.434 | 219.237 | 212.291 | 210.827 | 205.468 |
| K/w-verhouding | 30,4 x | 26,7 x | 8,2 x | 28,3 x | 14,1 x | 19,4 x | 16,7 x | 15,1 x |
| Dividendrendement | 3,19% | 3,56% | 3,83% | 3,87% | 3,79% | 3,69% | 3,82% | 4,02% |
| Marktkapitalisatie/omzet | 4,53 x | 4,43 x | 3,81 x | 3,85 x | 4,56 x | 4,09 x | 3,94 x | 3,91 x |
| Bedrijfswaarde/omzet | 4,86 x | 4,94 x | 3,96 x | 4,02 x | 4,82 x | 4,35 x | 4,17 x | 4,02 x |
| Bedrijfswaarde/EBITDA | 14,6 x | 14,3 x | 11,2 x | 10,9 x | 12,2 x | 11 x | 10,3 x | 9,83 x |
| Bedrijfswaarde/FCF | 17,9 x | 20,5 x | 15,4 x | 17 x | 16,6 x | 15,2 x | 13,7 x | 12,6 x |
| FCF Yield | 5,58% | 4,87% | 6,49% | 5,87% | 6,01% | 6,6% | 7,33% | 7,93% |
| Price to Book | 3,87 x | 3,78 x | 2,9 x | 3,23 x | 4,42 x | 4,46 x | 4,42 x | 4,15 x |
| Aantal aandelen (in duizenden) | 2.264.608 | 2.274.506 | 2.237.092 | 2.150.980 | 2.055.460 | 2.040.406 | - | - |
| Referentieprijs 2 | 94,81 | 94,83 | 87,83 | 90,38 | 100,8 | 97,84 | 97,84 | 97,84 |
| Datum van publicatie | 29-01-20 | 26-01-21 | 02-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 47.445 | 48.659 | 51.626 | 50.545 | 45.440 | 48.785 | 50.616 | 51.104 |
| EBITDA 1 | 15.809 | 16.845 | 18.246 | 18.613 | 17.937 | 19.290 | 20.468 | 20.898 |
| Bedrijfsresultaat (EBIT) 1 | 14.112 | 15.416 | 16.588 | 16.665 | 16.372 | 18.126 | 19.240 | 19.542 |
| Operationele Marge | 29,74% | 31,68% | 32,13% | 32,97% | 36,03% | 37,15% | 38,01% | 38,24% |
| Resultaat voor belastingen (EBT) 1 | 8.940 | 9.878 | 26.137 | 8.371 | 9.123 | 12.843 | 14.491 | 15.043 |
| Nettowinst (verlies) 1 | 7.147 | 8.072 | 24.021 | 6.955 | 14.854 | 10.372 | 11.895 | 12.811 |
| Nettomarge | 15,06% | 16,59% | 46,53% | 13,76% | 32,69% | 21,26% | 23,5% | 25,07% |
| WPA 2 | 3,120 | 3,550 | 10,71 | 3,190 | 7,150 | 5,056 | 5,867 | 6,472 |
| Free Cash Flow 1 | 12.875 | 11.691 | 13.282 | 11.945 | 13.179 | 14.004 | 15.444 | 16.290 |
| FCF-marge | 27,14% | 24,03% | 25,73% | 23,63% | 29% | 28,71% | 30,51% | 31,88% |
| Kasstroomconversie (ebitda) | 81,44% | 69,4% | 72,79% | 64,18% | 73,47% | 72,59% | 75,45% | 77,95% |
| Kasstroomconversie (nettowinst) | 180,15% | 144,83% | 55,29% | 171,75% | 88,72% | 135,01% | 129,83% | 127,16% |
| Dividend per aandeel 2 | 3,025 | 3,375 | 3,360 | 3,500 | 3,823 | 3,608 | 3,740 | 3,934 |
| Datum van publicatie | 29-01-20 | 26-01-21 | 02-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 13.229 | 12.531 | 12.781 | 12.543 | 12.690 | 12.953 | 13.622 | 11.782 | 11.423 | 11.829 | 12.253 | 12.477 | 12.766 | 11.905 | 12.155 |
| EBITDA | 4.274 | 4.407 | 4.989 | 4.783 | 4.473 | - | 4.668 | - | 4.224 | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 3.819 | 4.083 | 4.270 | 4.282 | 4.030 | 4.413 | 4.668 | 4.405 | 3.821 | 4.537 | 4.588 | 4.697 | 4.542 | 4.790 | 4.895 |
| Operationele Marge | 28,87% | 32,58% | 33,41% | 34,14% | 31,76% | 34,07% | 34,27% | 37,39% | 33,45% | 38,35% | 37,45% | 37,64% | 35,58% | 40,24% | 40,27% |
| Resultaat voor belastingen (EBT) 1 | 16.951 | 2.669 | 2.042 | 1.919 | 1.741 | 2.740 | 2.769 | 1.552 | 2.377 | 3.129 | 3.856 | 3.880 | 3.665 | - | - |
| Nettowinst (verlies) 1 | 16.308 | 2.222 | 1.695 | 1.575 | 1.466 | 2.293 | 2.316 | 1.513 | 8.480 | 2.688 | 2.777 | 2.814 | 2.515 | - | - |
| Nettomarge | 123,27% | 17,73% | 13,26% | 12,56% | 11,55% | 17,7% | 17% | 12,84% | 74,24% | 22,72% | 22,66% | 22,55% | 19,7% | - | - |
| WPA 2 | 7,290 | 1,000 | 0,7700 | 0,7300 | 0,6900 | 1,090 | 1,110 | 0,7300 | 4,140 | 1,310 | 1,358 | 1,386 | 1,252 | - | - |
| Dividend per aandeel 2 | 3,360 | - | - | - | 3,500 | - | - | - | 3,823 | - | 0,9494 | 0,9494 | 0,9494 | 1,014 | 1,014 |
| Datum van publicatie | 02-02-22 | 26-04-22 | 19-07-22 | 25-10-22 | 01-02-23 | 25-04-23 | 18-07-23 | 24-10-23 | 31-01-24 | 23-04-24 | - | - | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | 15.900 | 24.500 | 8.191 | 9.034 | 12.011 | 12.649 | 11.185 | 5.827 |
| Nettokaspositie 1 | - | - | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | 1,006 x | 1,454 x | 0,4489 x | 0,4854 x | 0,6696 x | 0,6557 x | 0,5464 x | 0,2788 x |
| Free Cash Flow 1 | 12.875 | 11.691 | 13.282 | 11.945 | 13.179 | 14.004 | 15.444 | 16.290 |
| ROE (netto-inkomsten/eigen vermogen) | 17,5% | 23,5% | 22,7% | 21% | 25,4% | 32,2% | 38% | 37,5% |
| ROA (netto-inkomsten/totale activa) | 8,89% | 6,45% | 10,9% | 10,7% | 12,4% | 10,7% | 12,8% | 14,2% |
| Totale activa 1 | 80.393 | 125.215 | 221.201 | 64.915 | 120.082 | 96.509 | 92.941 | 90.135 |
| Nettoactief per aandeel 2 | 24,50 | 25,10 | 30,30 | 28,00 | 22,80 | 21,90 | 22,10 | 23,60 |
| Cashflow per aandeel 2 | 5,880 | 5,950 | 6,670 | 6,480 | 6,910 | 7,710 | 8,280 | 8,540 |
| Capex 1 | 2.257 | 1.275 | 1.378 | 1.198 | 1.060 | 1.251 | 1.251 | 1.289 |
| Capex/omzet | 4,76% | 2,62% | 2,67% | 2,37% | 2,33% | 2,56% | 2,47% | 2,52% |
| Datum van publicatie | 29-01-20 | 26-01-21 | 02-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B-
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
20
Laatste slotkoers
97,84
USD
Gemiddelde koersdoel
108,5
USD
Spread / Gemiddelde doel
+10,88%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +5,46% | 200 mld. | |
| +25,83% | 661 mld. | |
| +27,00% | 566 mld. | |
| -6,76% | 352 mld. | |
| +20,34% | 332 mld. | |
| +3,00% | 283 mld. | |
| +13,09% | 231 mld. | |
| -9,61% | 195 mld. | |
| -6,26% | 145 mld. | |
| -11,77% | 144 mld. |
- Beurs
- Aandelen
- Koers NOVN
- Financiën Novartis AG
